A microfluidic platform for high-purity cell free DNA extraction from plasma for non-invasive prenatal testing.
Lindsay SchneiderThomas UsherwoodAnubhav TripathiPublished in: Prenatal diagnosis (2022)
This technique has the potential to improve NIPT outcomes and other clinically relevant workflows that use cfDNA as an analyte such as cancer detection.